Efficacy of Topical Lidocaine/Prilocaine in Pain Management in Pleurocentesis
Pleural Effusion
About this trial
This is an interventional treatment trial for Pleural Effusion
Eligibility Criteria
Inclusion Criteria: All Patients will be prepared for pleurocentesis. Exclusion Criteria: Patients with a known history of sensitivity to local anesthetics of the amide type or to any other component of the product. Patients treated with class III anti-arrhythmic drugs (e.g., amiodarone, bretylium, sotalol, dofetilide).
Sites / Locations
- Assuit University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Pridocaine cream
Standardized local lidocaine infiltration
Pridocaine cream (lidocaine 2.5% and prilocaine 2.5%) will be applied at least 30 min before the pleurocentesis on the skin overlying the chosen aspiration site using ultrasound under occlusive dressing over a 5 × 5 cm area.
Anesthetize the skin over the insertion site with 1% lidocaine using the 5 ml syringe with a 25 or 27-gauge needle. Next, anesthetize the superior surface of the rib and the pleura. The needle is inserted over the top of the rib (superior margin) to avoid the intercostal nerves and blood vessels that run on the underside of the rib (the intercostal nerve and the blood supply are located near the inferior margin). As the needle is inserted, aspirate back on the syringe to check for pleural fluid. Once fluid returns, note the depth of the needle and mark it with a hemostat. This gives an approximate depth for the insertion of the thoracentesis needle. Remove the anesthetizing needle.